China DSIP 2mg/vial Peptides High Quality

Description

Delta sleep-inducing peptide (DSIP) is a naturally occurring substance, which was originally isolated from rabbit brain in 1977. This curious substance is a nonapeptide that is normally synthesized in the hypothalamus and targets multiple sites including some within the brainstem. As its name suggests DSIP promotes sleep and this has been demonstrated in rabbits, mice, rats, cats and human beings.

In fact DSIP promotes a particular type of sleep which is characterized by an increase in the delta rhythm of the EEG.DSIP is normally present in minute amounts in the blood. Brain and plasma DSIP concentrations exhibit a marked diurnal variation and there has been shown to be a correlation between DSIP plasma concentrations and circadian rhythm in human beings. Concentrations are low in the mornings and higher in the afternoons.

An elevation of endogenous DSIP concentration has been shown to be associated with suppression of both slow-wave sleep and rapideye-movement sleep and interestingly also with body temperature. Plasma concentrations of DSIP are in¯uenced by the initiation of sleep . Patients with Cushing's syndrome suffer from a lack of slow-wave sleep but the diurnal variation in slow-wave and rapid-eye-movement sleep in those patients appears to be similar to that in normal patients.

When compared with most other peptides, DSIP is unusual in that it can freely cross the blood±brain barrier and is readily absorbed from the gut without being denatured by enzymes.DSIP is present in relatively high concentrations in human milk (10±30 ng mL±1). Any mother who has breast-fed her babies will attest to the ability of a feed to induce sleep. However, a feed of arti®cial milk may have a similar effect, and it is not known whether DSIP concentrations are related to the sleep±wake cycle in human neonates.

DSIP has been synthesized. Administration of the synthetic substance does not induce tolerance .DSIP can be assayed by several techniques including radioimmunoassay (RIA), enzyme immunoassay and high-performance liquid chromatography with RIA.

DSIP has a half-life in human plasma of between 7 and 8 min. It is degraded in blood, the pathway involving the amino-peptidases . A potential drug interaction might therefore be envisaged between DSIP and drugs which inhibit or are themselves metabolized by peptidases. Captopril is one such agent and patients currently undergoing treatment with any of the angiotensin-converting enzyme inhibitors should probably be excluded from any DSIP treatment protocol until further studies have been undertaken.

The Health Benefits Of DSIP Peptides

Regulates Sleep Patterns

The most substantial benefit of DSIP is its influence on the regulation of sleeping patterns for humans. After the initial discovery of this peptide, more studies followed only to test the given hypothesis: "that DSIP may be the principal endogenous sleep factor." Additional reports came out about an increase in the sleep-prompting effect on human subjects injected with small doses. Other studies also found out its ability to induce delta-wave sleep. They led to future examinations on DSIP, specifically on the possibility that it could be an effective treatment for insomnia.

It is important to note that DSIP is not advisable to be used as an alternative to sedatives. Also, the results that yielded positive effects of DSIP involved subjects who were suffering from sleep disturbance. Healthy subjects who did not have complaints regarding a disrupted circadian rhythm yielded minimal significant results. Although, a full restoration on the circadian rhythm is still bound for more in-depth clinical research.

Regulates Secretion Of ACTH And LH Hormones

DSIP is also associated with the secretion of Adrenocorticotropic Hormone (ACTH). With a healthy circadian rhythm, ACTH follows the protocol of being at a high level in the morning (normal level), a gradual decrease during the day, and reaches the lowest level during the night. Some studies showed that DSIP significantly decreased ACTH levels, thus promoting the sleeping state of the body.

This peptide also stimulates the release of Luteinizing Hormone (LH) levels. This regulation helps in the inhibition of somatostatin, a growth hormone-inhibiting hormone (GHIH).

Analgesic For Chronic Pain

DSIP peptide has other unrelated properties that may be beneficial for chronic pain relief. For example, some studies show that it affects the reduction of amphetamine-induced hyperthermia.

"The agent has been used for the treatment of alcohol and opioid withdrawal with some success. Clinical symptoms and signs disappear after injection of DSIP, although some patients have reported occasional headaches. (Pollard & Pomfrett, 2001)"

Normalizes Blood Pressure

Moreover, DSIP also elicits antihypertensive effects.

A study on spontaneously hypertensive rats (SHR) measured that within ten days of DSIP infusion, it resulted in the maintenance of blood pressure at a certain level.

Recommendations

There are possible side effects on short-term or long-term use of DSIP peptides. However, no significant side-effects have so far been reported with the use of DSIP, whether on animals or humans. Nonetheless, It is recommendable to consult your doctor before taking any peptide products.

Other Uses For DSIP

In addition to its potential impact on sleep, DSIP has also been studied for a range of other uses due to its potential interactions with neurotransmitters such as dopamine and serotonin.

●DSIP may also be used for:

●Immune function

●Antioxidant and anti-inflammatory properties

●Anxiety and depression

●Pain regulation

●Blood pressure

●Regulate circadian rhythm

Although it is generally considered safe when taken in low doses, DSIP should only be used with the guidance of a qualified healthcare professional.

This peptide is still being researched to fully understand its potential effects on sleep and stress, as well as its potential side effects and medication interactions.